Comparison of Computerized Prescription Support Systems in COVID-19 Patients: INTERCheck and Drug-PIN

The coronavirus disease 19 (COVID-19) infection requires major efforts in healthcare systems, due to the high risk of mortality, particularly in subjects with significant comorbidity (≥ 2 pathologies) and polypharmacy (≥ 5 drugs). The treatment of COVID-19 needs a careful evaluation, to reduce the r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:SN comprehensive clinical medicine 2022, Vol.4 (1), p.3-3, Article 3
Hauptverfasser: Martocchia, Antonio, Bruscia, Clara, Conforti, Giulia, Falangone, Francesca, Marini, Valentina, Pennica, Alfredo, Pezzuto, Aldo, March, Massimiliano Rocchietti, Sentimentale, Alberto, Spuntarelli, Valerio, Tafaro, Laura, Ricci, Alberto, Simmaco, Maurizio, Sesti, Giorgio, Preissner, Robert, Martelletti, Paolo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3
container_issue 1
container_start_page 3
container_title SN comprehensive clinical medicine
container_volume 4
creator Martocchia, Antonio
Bruscia, Clara
Conforti, Giulia
Falangone, Francesca
Marini, Valentina
Pennica, Alfredo
Pezzuto, Aldo
March, Massimiliano Rocchietti
Sentimentale, Alberto
Spuntarelli, Valerio
Tafaro, Laura
Ricci, Alberto
Simmaco, Maurizio
Sesti, Giorgio
Preissner, Robert
Martelletti, Paolo
description The coronavirus disease 19 (COVID-19) infection requires major efforts in healthcare systems, due to the high risk of mortality, particularly in subjects with significant comorbidity (≥ 2 pathologies) and polypharmacy (≥ 5 drugs). The treatment of COVID-19 needs a careful evaluation, to reduce the risk of potentially adverse drug reactions. The aim of the study was to examine the use of computerized prescription support in the management and treatment of the COVID-19 infection. We evaluated n.33 patients (51% females) admitted to the west COVID Low-Medium Intensity of Care of Sant’Andrea Hospital during the period March–April 2020 and n.42 subjects (50% females) admitted to the Internal Medicine ward (as control group), by INTERCheck® and Drug-PIN®. The comorbidity (n. pathologies), polypharmacy (n. drugs), and total INTERCheck score in COVID-19 patients and controls were, respectively (mean ± standard deviation): 5.8 ± 3.8, 7.9 ± 4.5, and 9.2 ± 7.1 and 6.8 ± 2.6, 8.0 ± 2.6, and 4.9 ± 3.8 (statistically significant for comorbidity p  
doi_str_mv 10.1007/s42399-021-01079-9
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8710931</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2616290556</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2919-5b038dbbb69a531a680a7304b849817765296ca5fa36147f44a8b7ffb38566fa3</originalsourceid><addsrcrecordid>eNp9kUtP3DAUhS1UxKCBP8ACedmNi9-Ou6hUBWhHQjDitbWcjDNjOolTO0Ga_npMBxBsWPlxvnvu1T0AHBH8jWCsThKnTGuEKUGYYKWR3gH7VFCGCq3Yl3f3CThM6QHjjHIusNoDE8a1UlyyfeDK0PY2-hQ6GBr4_BoHF_0_t4Dz6FIdfT_4LN6MfR_iAG82aXBtgr6D5dX97BQRDed28K4b0nc4u7w9uy5Xrv4DbbeAp3Fcovns8gDsNnad3OHLOQV352e35W90cfVrVv68QDXVRCNRYVYsqqqS2gpGrCywVQzzquC6IEpJQbWsrWgsk4SrhnNbVKppKlYIKfPvFPzY-vZj1bpFnYeKdm366FsbNyZYbz4qnV-ZZXg0hSJYM5INvr4YxPB3dGkwrU-1W69t58KYDJVEUo2FkBmlW7SOIaXomrc2BJvniMw2IpP3bv5HZHQuOn4_4FvJayAZYFsgZalbumgewhi7vLTPbJ8Aoteb3Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2616290556</pqid></control><display><type>article</type><title>Comparison of Computerized Prescription Support Systems in COVID-19 Patients: INTERCheck and Drug-PIN</title><source>SpringerLink Journals - AutoHoldings</source><creator>Martocchia, Antonio ; Bruscia, Clara ; Conforti, Giulia ; Falangone, Francesca ; Marini, Valentina ; Pennica, Alfredo ; Pezzuto, Aldo ; March, Massimiliano Rocchietti ; Sentimentale, Alberto ; Spuntarelli, Valerio ; Tafaro, Laura ; Ricci, Alberto ; Simmaco, Maurizio ; Sesti, Giorgio ; Preissner, Robert ; Martelletti, Paolo</creator><creatorcontrib>Martocchia, Antonio ; Bruscia, Clara ; Conforti, Giulia ; Falangone, Francesca ; Marini, Valentina ; Pennica, Alfredo ; Pezzuto, Aldo ; March, Massimiliano Rocchietti ; Sentimentale, Alberto ; Spuntarelli, Valerio ; Tafaro, Laura ; Ricci, Alberto ; Simmaco, Maurizio ; Sesti, Giorgio ; Preissner, Robert ; Martelletti, Paolo</creatorcontrib><description>The coronavirus disease 19 (COVID-19) infection requires major efforts in healthcare systems, due to the high risk of mortality, particularly in subjects with significant comorbidity (≥ 2 pathologies) and polypharmacy (≥ 5 drugs). The treatment of COVID-19 needs a careful evaluation, to reduce the risk of potentially adverse drug reactions. The aim of the study was to examine the use of computerized prescription support in the management and treatment of the COVID-19 infection. We evaluated n.33 patients (51% females) admitted to the west COVID Low-Medium Intensity of Care of Sant’Andrea Hospital during the period March–April 2020 and n.42 subjects (50% females) admitted to the Internal Medicine ward (as control group), by INTERCheck® and Drug-PIN®. The comorbidity (n. pathologies), polypharmacy (n. drugs), and total INTERCheck score in COVID-19 patients and controls were, respectively (mean ± standard deviation): 5.8 ± 3.8, 7.9 ± 4.5, and 9.2 ± 7.1 and 6.8 ± 2.6, 8.0 ± 2.6, and 4.9 ± 3.8 (statistically significant for comorbidity p  &lt; 0.01 and INTERCheck score p  &lt; 0.01). The correlation between the scores obtained by the INTERCheck and Drug-PIN software was statistically significant, either at admission ( p  &lt; 0.0000001) or during hospitalization ( p  &lt; 0.00000001). Both the computerized prescription support systems, INTERCheck® and Drug-PIN®, are useful to better characterize the patients and to ameliorate the drugs prescriptions in COVID-19 infection, with particular attention to the elderly population.</description><identifier>ISSN: 2523-8973</identifier><identifier>EISSN: 2523-8973</identifier><identifier>DOI: 10.1007/s42399-021-01079-9</identifier><identifier>PMID: 34977463</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Brief Communication ; Medicine ; Medicine &amp; Public Health ; Topical Collection on COVID-19</subject><ispartof>SN comprehensive clinical medicine, 2022, Vol.4 (1), p.3-3, Article 3</ispartof><rights>The Author(s), under exclusive licence to Springer Nature Switzerland AG 2021</rights><rights>The Author(s), under exclusive licence to Springer Nature Switzerland AG 2021.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2919-5b038dbbb69a531a680a7304b849817765296ca5fa36147f44a8b7ffb38566fa3</citedby><cites>FETCH-LOGICAL-c2919-5b038dbbb69a531a680a7304b849817765296ca5fa36147f44a8b7ffb38566fa3</cites><orcidid>0000-0002-6201-5377</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s42399-021-01079-9$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s42399-021-01079-9$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,780,784,885,4024,27923,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34977463$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Martocchia, Antonio</creatorcontrib><creatorcontrib>Bruscia, Clara</creatorcontrib><creatorcontrib>Conforti, Giulia</creatorcontrib><creatorcontrib>Falangone, Francesca</creatorcontrib><creatorcontrib>Marini, Valentina</creatorcontrib><creatorcontrib>Pennica, Alfredo</creatorcontrib><creatorcontrib>Pezzuto, Aldo</creatorcontrib><creatorcontrib>March, Massimiliano Rocchietti</creatorcontrib><creatorcontrib>Sentimentale, Alberto</creatorcontrib><creatorcontrib>Spuntarelli, Valerio</creatorcontrib><creatorcontrib>Tafaro, Laura</creatorcontrib><creatorcontrib>Ricci, Alberto</creatorcontrib><creatorcontrib>Simmaco, Maurizio</creatorcontrib><creatorcontrib>Sesti, Giorgio</creatorcontrib><creatorcontrib>Preissner, Robert</creatorcontrib><creatorcontrib>Martelletti, Paolo</creatorcontrib><title>Comparison of Computerized Prescription Support Systems in COVID-19 Patients: INTERCheck and Drug-PIN</title><title>SN comprehensive clinical medicine</title><addtitle>SN Compr. Clin. Med</addtitle><addtitle>SN Compr Clin Med</addtitle><description>The coronavirus disease 19 (COVID-19) infection requires major efforts in healthcare systems, due to the high risk of mortality, particularly in subjects with significant comorbidity (≥ 2 pathologies) and polypharmacy (≥ 5 drugs). The treatment of COVID-19 needs a careful evaluation, to reduce the risk of potentially adverse drug reactions. The aim of the study was to examine the use of computerized prescription support in the management and treatment of the COVID-19 infection. We evaluated n.33 patients (51% females) admitted to the west COVID Low-Medium Intensity of Care of Sant’Andrea Hospital during the period March–April 2020 and n.42 subjects (50% females) admitted to the Internal Medicine ward (as control group), by INTERCheck® and Drug-PIN®. The comorbidity (n. pathologies), polypharmacy (n. drugs), and total INTERCheck score in COVID-19 patients and controls were, respectively (mean ± standard deviation): 5.8 ± 3.8, 7.9 ± 4.5, and 9.2 ± 7.1 and 6.8 ± 2.6, 8.0 ± 2.6, and 4.9 ± 3.8 (statistically significant for comorbidity p  &lt; 0.01 and INTERCheck score p  &lt; 0.01). The correlation between the scores obtained by the INTERCheck and Drug-PIN software was statistically significant, either at admission ( p  &lt; 0.0000001) or during hospitalization ( p  &lt; 0.00000001). Both the computerized prescription support systems, INTERCheck® and Drug-PIN®, are useful to better characterize the patients and to ameliorate the drugs prescriptions in COVID-19 infection, with particular attention to the elderly population.</description><subject>Brief Communication</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Topical Collection on COVID-19</subject><issn>2523-8973</issn><issn>2523-8973</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kUtP3DAUhS1UxKCBP8ACedmNi9-Ou6hUBWhHQjDitbWcjDNjOolTO0Ga_npMBxBsWPlxvnvu1T0AHBH8jWCsThKnTGuEKUGYYKWR3gH7VFCGCq3Yl3f3CThM6QHjjHIusNoDE8a1UlyyfeDK0PY2-hQ6GBr4_BoHF_0_t4Dz6FIdfT_4LN6MfR_iAG82aXBtgr6D5dX97BQRDed28K4b0nc4u7w9uy5Xrv4DbbeAp3Fcovns8gDsNnad3OHLOQV352e35W90cfVrVv68QDXVRCNRYVYsqqqS2gpGrCywVQzzquC6IEpJQbWsrWgsk4SrhnNbVKppKlYIKfPvFPzY-vZj1bpFnYeKdm366FsbNyZYbz4qnV-ZZXg0hSJYM5INvr4YxPB3dGkwrU-1W69t58KYDJVEUo2FkBmlW7SOIaXomrc2BJvniMw2IpP3bv5HZHQuOn4_4FvJayAZYFsgZalbumgewhi7vLTPbJ8Aoteb3Q</recordid><startdate>2022</startdate><enddate>2022</enddate><creator>Martocchia, Antonio</creator><creator>Bruscia, Clara</creator><creator>Conforti, Giulia</creator><creator>Falangone, Francesca</creator><creator>Marini, Valentina</creator><creator>Pennica, Alfredo</creator><creator>Pezzuto, Aldo</creator><creator>March, Massimiliano Rocchietti</creator><creator>Sentimentale, Alberto</creator><creator>Spuntarelli, Valerio</creator><creator>Tafaro, Laura</creator><creator>Ricci, Alberto</creator><creator>Simmaco, Maurizio</creator><creator>Sesti, Giorgio</creator><creator>Preissner, Robert</creator><creator>Martelletti, Paolo</creator><general>Springer International Publishing</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6201-5377</orcidid></search><sort><creationdate>2022</creationdate><title>Comparison of Computerized Prescription Support Systems in COVID-19 Patients: INTERCheck and Drug-PIN</title><author>Martocchia, Antonio ; Bruscia, Clara ; Conforti, Giulia ; Falangone, Francesca ; Marini, Valentina ; Pennica, Alfredo ; Pezzuto, Aldo ; March, Massimiliano Rocchietti ; Sentimentale, Alberto ; Spuntarelli, Valerio ; Tafaro, Laura ; Ricci, Alberto ; Simmaco, Maurizio ; Sesti, Giorgio ; Preissner, Robert ; Martelletti, Paolo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2919-5b038dbbb69a531a680a7304b849817765296ca5fa36147f44a8b7ffb38566fa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Brief Communication</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Topical Collection on COVID-19</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Martocchia, Antonio</creatorcontrib><creatorcontrib>Bruscia, Clara</creatorcontrib><creatorcontrib>Conforti, Giulia</creatorcontrib><creatorcontrib>Falangone, Francesca</creatorcontrib><creatorcontrib>Marini, Valentina</creatorcontrib><creatorcontrib>Pennica, Alfredo</creatorcontrib><creatorcontrib>Pezzuto, Aldo</creatorcontrib><creatorcontrib>March, Massimiliano Rocchietti</creatorcontrib><creatorcontrib>Sentimentale, Alberto</creatorcontrib><creatorcontrib>Spuntarelli, Valerio</creatorcontrib><creatorcontrib>Tafaro, Laura</creatorcontrib><creatorcontrib>Ricci, Alberto</creatorcontrib><creatorcontrib>Simmaco, Maurizio</creatorcontrib><creatorcontrib>Sesti, Giorgio</creatorcontrib><creatorcontrib>Preissner, Robert</creatorcontrib><creatorcontrib>Martelletti, Paolo</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>SN comprehensive clinical medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Martocchia, Antonio</au><au>Bruscia, Clara</au><au>Conforti, Giulia</au><au>Falangone, Francesca</au><au>Marini, Valentina</au><au>Pennica, Alfredo</au><au>Pezzuto, Aldo</au><au>March, Massimiliano Rocchietti</au><au>Sentimentale, Alberto</au><au>Spuntarelli, Valerio</au><au>Tafaro, Laura</au><au>Ricci, Alberto</au><au>Simmaco, Maurizio</au><au>Sesti, Giorgio</au><au>Preissner, Robert</au><au>Martelletti, Paolo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of Computerized Prescription Support Systems in COVID-19 Patients: INTERCheck and Drug-PIN</atitle><jtitle>SN comprehensive clinical medicine</jtitle><stitle>SN Compr. Clin. Med</stitle><addtitle>SN Compr Clin Med</addtitle><date>2022</date><risdate>2022</risdate><volume>4</volume><issue>1</issue><spage>3</spage><epage>3</epage><pages>3-3</pages><artnum>3</artnum><issn>2523-8973</issn><eissn>2523-8973</eissn><abstract>The coronavirus disease 19 (COVID-19) infection requires major efforts in healthcare systems, due to the high risk of mortality, particularly in subjects with significant comorbidity (≥ 2 pathologies) and polypharmacy (≥ 5 drugs). The treatment of COVID-19 needs a careful evaluation, to reduce the risk of potentially adverse drug reactions. The aim of the study was to examine the use of computerized prescription support in the management and treatment of the COVID-19 infection. We evaluated n.33 patients (51% females) admitted to the west COVID Low-Medium Intensity of Care of Sant’Andrea Hospital during the period March–April 2020 and n.42 subjects (50% females) admitted to the Internal Medicine ward (as control group), by INTERCheck® and Drug-PIN®. The comorbidity (n. pathologies), polypharmacy (n. drugs), and total INTERCheck score in COVID-19 patients and controls were, respectively (mean ± standard deviation): 5.8 ± 3.8, 7.9 ± 4.5, and 9.2 ± 7.1 and 6.8 ± 2.6, 8.0 ± 2.6, and 4.9 ± 3.8 (statistically significant for comorbidity p  &lt; 0.01 and INTERCheck score p  &lt; 0.01). The correlation between the scores obtained by the INTERCheck and Drug-PIN software was statistically significant, either at admission ( p  &lt; 0.0000001) or during hospitalization ( p  &lt; 0.00000001). Both the computerized prescription support systems, INTERCheck® and Drug-PIN®, are useful to better characterize the patients and to ameliorate the drugs prescriptions in COVID-19 infection, with particular attention to the elderly population.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>34977463</pmid><doi>10.1007/s42399-021-01079-9</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-6201-5377</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2523-8973
ispartof SN comprehensive clinical medicine, 2022, Vol.4 (1), p.3-3, Article 3
issn 2523-8973
2523-8973
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8710931
source SpringerLink Journals - AutoHoldings
subjects Brief Communication
Medicine
Medicine & Public Health
Topical Collection on COVID-19
title Comparison of Computerized Prescription Support Systems in COVID-19 Patients: INTERCheck and Drug-PIN
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T04%3A42%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20Computerized%20Prescription%20Support%20Systems%20in%20COVID-19%20Patients:%20INTERCheck%20and%20Drug-PIN&rft.jtitle=SN%20comprehensive%20clinical%20medicine&rft.au=Martocchia,%20Antonio&rft.date=2022&rft.volume=4&rft.issue=1&rft.spage=3&rft.epage=3&rft.pages=3-3&rft.artnum=3&rft.issn=2523-8973&rft.eissn=2523-8973&rft_id=info:doi/10.1007/s42399-021-01079-9&rft_dat=%3Cproquest_pubme%3E2616290556%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2616290556&rft_id=info:pmid/34977463&rfr_iscdi=true